The US open surgery instrument market will\u00a0expand gradually\u00a0through 2033. This growth will be driven by the continued adoption of advanced, premium-priced technologies, such as direct energy devices and closure devices. However, the market will continue to shift toward\u00a0MIS, including laparoscopic and robotic-assisted techniques, limiting demand for open surgeries, although the lack of additional reimbursement for robotic-assisted procedures will hinder the pace of\u00a0RAS\u00a0procedure volume growth to some extent. Additionally, the rising use of GLP-1 receptor agonists, which is reducing demand for bariatric surgeries, will dampen market growth to some extent.<\/p>\n
This Medtech 360 Report provides comprehensive data and analysis on the state of the US open surgery instrument market from 2019 through 2033.<\/p>\n","protected":false},"template":"","class_list":["post-538504","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-open-surgery-instruments","medtech-date-983"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/538504","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/538504\/revisions"}],"predecessor-version":[{"id":538761,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/538504\/revisions\/538761"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=538504"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}